Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecular investigation of hepatitis C virus before and after daclatasvir plus sofosbuvir therapy
IRCT20171125037624N2Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of daclatasvir and sofosbuvir in hepatitis C virus infection (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: HCV viral load. Started Apr 2017; status: completed.
02
Drugs
daclatasvirsofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on IRCT20171125037624N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171125037624N2.